Dysregulation of BMP9/BMPR2/SMAD signalling pathway contributes to pulmonary fibrosis and pulmonary hypertension induced by bleomycin in rats.

Qian JiangChunli LiuShiyun LiuWenju LuYi LiXiaoyun LuoRan MaChenting ZhangHaixia ChenYuqin ChenZizhou ZhangCheng HongWenliang GuoTao WangKai Yang Jian Wang

Published in: British journal of pharmacology (2020)

This article is part of a themed issue on Risk factors, comorbidities, and comedications in cardioprotection. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.1/issuetoc.

Keyphrases

pulmonary fibrosis
pulmonary hypertension
pulmonary arterial hypertension
risk factors
pulmonary artery
epithelial mesenchymal transition
mesenchymal stem cells
transforming growth factor
benign prostatic hyperplasia
lower urinary tract symptoms
bone regeneration
signaling pathway